Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santosh R D'Mello

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Drug News & Perspectives|January 15, 2010
Histone deacetylases as targets for the treatment of human neurodegenerative diseasesSantosh R D'Mello
Developmental Neuroscience|January 27, 2020
Regulation of Central Nervous System Development by Class I Histone DeacetylasesSantosh R D'Mello
Experimental Biology and Medicine (Maywood, N.J.)|December 7, 2023
Rett and Rett-related disorders: Common mechanisms for shared symptoms?Santosh R D'Mello
Journal of Neurochemistry|February 27, 2021
MECP2 and the biology of MECP2 duplication syndromeSantosh R D'Mello
Neurology International|October 28, 2025
Autism Spectrum Disorder: The Cerebellum, Genes, and PathwaysSantosh R D'Mello
Experimental Biology and Medicine (Maywood, N.J.)|June 4, 2020
Histone deacetylase-3: Friend and foe of the brainSantosh R D'Mello
International Journal of Molecular Sciences|June 2, 2021
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's DiseaseSantosh R D'Mello
Current Opinion in Pharmacology|January 6, 2020
Histone deacetylases 1, 2 and 3 in nervous system developmentSantosh R D'Mello
The Journal of Biological Chemistry|December 2, 2010
Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanismChi Ma, Santosh R D'Mello
Biochimica Et Biophysica Acta|October 29, 2003
NF-kappaB stimulates Akt phosphorylation and gene expression by distinct signaling mechanismsFanyin Meng, Santosh R D'Mello
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Drug News & Perspectives|January 15, 2010
Histone deacetylases as targets for the treatment of human neurodegenerative diseasesSantosh R D'Mello
Developmental Neuroscience|January 27, 2020
Regulation of Central Nervous System Development by Class I Histone DeacetylasesSantosh R D'Mello
Experimental Biology and Medicine (Maywood, N.J.)|December 7, 2023
Rett and Rett-related disorders: Common mechanisms for shared symptoms?Santosh R D'Mello
Journal of Neurochemistry|February 27, 2021
MECP2 and the biology of MECP2 duplication syndromeSantosh R D'Mello
Neurology International|October 28, 2025
Autism Spectrum Disorder: The Cerebellum, Genes, and PathwaysSantosh R D'Mello
Experimental Biology and Medicine (Maywood, N.J.)|June 4, 2020
Histone deacetylase-3: Friend and foe of the brainSantosh R D'Mello
International Journal of Molecular Sciences|June 2, 2021
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's DiseaseSantosh R D'Mello
Current Opinion in Pharmacology|January 6, 2020
Histone deacetylases 1, 2 and 3 in nervous system developmentSantosh R D'Mello
The Journal of Biological Chemistry|December 2, 2010
Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanismChi Ma, Santosh R D'Mello
Biochimica Et Biophysica Acta|October 29, 2003
NF-kappaB stimulates Akt phosphorylation and gene expression by distinct signaling mechanismsFanyin Meng, Santosh R D'Mello
Pageof 6